These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 34419065)

  • 21. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
    Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
    Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
    [No Abstract]   [Full Text] [Related]  

  • 23. LncRNA OIP5-AS1 Upregulates the Cyclin D2 Levels to Promote Metastasis of Breast Cancer by Targeting miR-150-5p.
    Wu H; Huang Q; Xu T; Zhang J; Zeng J; Wang Q; Zhang Y; Yu Z
    Appl Biochem Biotechnol; 2024 Jun; ():. PubMed ID: 38888699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
    Chang X; Lin YY; Bai LN; Zhu W
    J Chemother; 2022 Feb; 34(1):55-66. PubMed ID: 34286671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer.
    Zhou S; Sheng L; Zhang L; Zhang J; Wang L
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130542. PubMed ID: 38103759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.
    Wang J; Wang W; Huang X; Cao J; Hou S; Ni X; Peng C; Liu T
    J Bone Oncol; 2022 Feb; 32():100411. PubMed ID: 35145841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
    Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression.
    Rong D; Wu F; Lu C; Sun G; Shi X; Chen X; Dai Y; Zhong W; Hao X; Zhou J; Xia Y; Tang W; Wang X
    Mol Ther Nucleic Acids; 2021 Dec; 26():637-648. PubMed ID: 34703649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3-Mediated m
    Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
    Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3/
    Xiong J; Lian W; Zhao R; Gao K
    Onco Targets Ther; 2024; 17():85-97. PubMed ID: 38348427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C; Ren Q; Deng J; Wang S; Ren L
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Gong Y; Luo G; Zhang S; Chen Y; Hu Y
    Cell Signal; 2024 May; 117():111068. PubMed ID: 38286198
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Huang S; Chen B; Qiu P; Yan Z; Liang Z; Luo K; Huang B; Jiang H
    Transl Cancer Res; 2023 Jun; 12(6):1588-1601. PubMed ID: 37434681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.